JPWO2020254804A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020254804A5 JPWO2020254804A5 JP2021575438A JP2021575438A JPWO2020254804A5 JP WO2020254804 A5 JPWO2020254804 A5 JP WO2020254804A5 JP 2021575438 A JP2021575438 A JP 2021575438A JP 2021575438 A JP2021575438 A JP 2021575438A JP WO2020254804 A5 JPWO2020254804 A5 JP WO2020254804A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- construct
- sarna
- nucleotide sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1908729.5 | 2019-06-18 | ||
| GBGB1908729.5A GB201908729D0 (en) | 2019-06-18 | 2019-06-18 | RNA construct |
| PCT/GB2020/051465 WO2020254804A1 (fr) | 2019-06-18 | 2020-06-18 | Construction d'arn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537562A JP2022537562A (ja) | 2022-08-26 |
| JPWO2020254804A5 true JPWO2020254804A5 (fr) | 2023-06-22 |
Family
ID=67432317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575438A Pending JP2022537562A (ja) | 2019-06-18 | 2020-06-18 | Ｒｎａ構築物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220265807A1 (fr) |
| EP (1) | EP3987042A1 (fr) |
| JP (1) | JP2022537562A (fr) |
| KR (1) | KR20220038669A (fr) |
| CN (1) | CN114402078A (fr) |
| AU (1) | AU2020296337A1 (fr) |
| BR (1) | BR112021024786A2 (fr) |
| CA (1) | CA3143117A1 (fr) |
| GB (1) | GB201908729D0 (fr) |
| IL (1) | IL288956A (fr) |
| MX (1) | MX2021015753A (fr) |
| WO (1) | WO2020254804A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019051642A1 (fr) * | 2017-09-12 | 2019-03-21 | 广州中科蓝华生物科技有限公司 | Kit pour la transfection de parasites intracellulaires et son utilisation |
| US11679163B2 (en) | 2019-09-20 | 2023-06-20 | Hdt Bio Corp. | Compositions and methods for delivery of RNA |
| US20210369759A1 (en) * | 2020-01-29 | 2021-12-02 | Helix Nanotechnologies, Inc. | METHODS AND COMPOSITIONS FOR NUCLEIC ACID EXPRESSION INVOLVING INHIBITION of NF-kB PATHWAYS AND/OR IRF PATHWAYS |
| US11759515B2 (en) | 2020-03-09 | 2023-09-19 | Arcturus Therapeutics, Inc. | Compositions and methods for inducing immune responses |
| JP2023518976A (ja) | 2020-03-23 | 2023-05-09 | エイチディーティー バイオ コーポレーション | Ｒｎａを送達するための組成物および方法 |
| GB202020061D0 (en) * | 2020-12-17 | 2021-02-03 | Imp College Innovations Ltd | RNA construct |
| EP4267593A2 (fr) | 2020-12-23 | 2023-11-01 | GlaxoSmithKline Biologicals SA | Arn messager auto-amplifiant |
| JP2024517848A (ja) | 2021-05-04 | 2024-04-23 | モグリファイ リミテッド | 細胞変換 |
| CN113249408B (zh) * | 2021-06-23 | 2021-11-02 | 深圳湾实验室 | 一种靶向激活体液免疫和细胞免疫的核酸疫苗载体构建及应用 |
| WO2023111592A1 (fr) * | 2021-12-17 | 2023-06-22 | Imperial College Innovations Limited | Construction d'arn |
| GB202203060D0 (en) | 2022-03-04 | 2022-04-20 | Imperial College Innovations Ltd | RNA molecule |
| WO2023220693A1 (fr) * | 2022-05-12 | 2023-11-16 | SunVax mRNA Therapeutics Inc. | Molécules d'arnm synthétiques à auto-amplification avec antigène de sécrétion et immunomodulateur |
| CN115820696A (zh) * | 2022-07-28 | 2023-03-21 | 怡道生物科技(苏州)有限公司 | 治疗性多价HPV mRNA疫苗及其制备方法 |
| WO2024181753A1 (fr) * | 2023-02-27 | 2024-09-06 | 주식회사 마이크로유니 | Construction d'arn auto-amplificatrice et son utilisation |
-
2019
- 2019-06-18 GB GBGB1908729.5A patent/GB201908729D0/en not_active Ceased
-
2020
- 2020-06-18 BR BR112021024786A patent/BR112021024786A2/pt unknown
- 2020-06-18 US US17/617,831 patent/US20220265807A1/en active Pending
- 2020-06-18 CA CA3143117A patent/CA3143117A1/fr active Pending
- 2020-06-18 MX MX2021015753A patent/MX2021015753A/es unknown
- 2020-06-18 KR KR1020227001607A patent/KR20220038669A/ko unknown
- 2020-06-18 JP JP2021575438A patent/JP2022537562A/ja active Pending
- 2020-06-18 EP EP20734803.8A patent/EP3987042A1/fr active Pending
- 2020-06-18 CN CN202080045184.7A patent/CN114402078A/zh active Pending
- 2020-06-18 WO PCT/GB2020/051465 patent/WO2020254804A1/fr unknown
- 2020-06-18 AU AU2020296337A patent/AU2020296337A1/en active Pending
-
2021
- 2021-12-13 IL IL288956A patent/IL288956A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230405107A1 (en) | Bunyavirales vaccine | |
| JPWO2020254804A5 (fr) | ||
| US20210330781A1 (en) | Induce and enhance immune responses using recombinant replicon systems | |
| US20230242593A1 (en) | Zika viral antigen constructs | |
| ES2890023T3 (es) | Partículas alfavíricas y métodos de preparación | |
| EP1773403B1 (fr) | Adjuvants à base d'alphavirus | |
| JP2021519595A (ja) | 新規ｒｓｖ ｒｎａ分子及びワクチン接種用組成物 | |
| KR20230164648A (ko) | SARS-CoV-2 변이체에 대한 RNA 백신 | |
| CN112048007B (zh) | 一种通用型新型冠状病毒疫苗及其制备方法 | |
| EP4157344A2 (fr) | Vaccins contre le coronavirus à base d'acides nucléiques multivalents | |
| WO2023035372A1 (fr) | Système moléculaire d'arnm à auto-réplication limitée, procédé de préparation et application | |
| JP2023551982A (ja) | マルチシストロン性ｒｎａワクチン及びその使用 | |
| CA3132188A1 (fr) | Compositions et methodes de prevention et/ou de traitement de la covid-19 | |
| WO2022133230A1 (fr) | Polythérapie pour le traitement d'une infection par le virus de l'hépatite b | |
| JP2008530032A (ja) | 腫瘍治療のためのフラビウイルスレプリコン構築物 | |
| Hidajat et al. | Next generation sequencing of DNA-launched Chikungunya vaccine virus | |
| CN117377491A (zh) | 免疫原性组合物 | |
| Yonemitsu et al. | Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen | |
| US20060018928A1 (en) | Virus-like particle containing a dengue virus recombinant replicon | |
| CN115975053A (zh) | 靶向新型冠状病毒的疫苗 | |
| US20160228531A1 (en) | Treatment of hepatitis d virus infections by redirection of t cells | |
| RU2022100963A (ru) | Рнк-конструкция | |
| WO2018092887A1 (fr) | Vaccin contre des maladies infectieuses utilisant des particules de paramyxovirus non infectieuses | |
| EP2647645A1 (fr) | Protéines recombinées de Parapoxvirus ovis et compositions pharmaceutiques produites à partir de celles-ci | |
| JPWO2020079427A5 (fr) |